BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 196 filers reported holding BEAM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $837,181 | -20.3% | 34,810 | +5.8% | 0.01% | -16.7% |
| Q2 2023 | $1,050,273 | +11.8% | 32,893 | +7.2% | 0.01% | 0.0% |
| Q1 2023 | $939,238 | -20.1% | 30,674 | +2.0% | 0.01% | -25.0% |
| Q4 2022 | $1,175,803 | -18.2% | 30,064 | -0.4% | 0.01% | -20.0% |
| Q3 2022 | $1,437,000 | +24.7% | 30,174 | +1.4% | 0.01% | +25.0% |
| Q2 2022 | $1,152,000 | -20.9% | 29,748 | +17.1% | 0.01% | 0.0% |
| Q1 2022 | $1,456,000 | -32.8% | 25,414 | -6.6% | 0.01% | -27.3% |
| Q4 2021 | $2,168,000 | -8.7% | 27,203 | -0.3% | 0.01% | -15.4% |
| Q3 2021 | $2,374,000 | -29.9% | 27,283 | +3.6% | 0.01% | +18.2% |
| Q2 2021 | $3,388,000 | +82.1% | 26,325 | +13.2% | 0.01% | +57.1% |
| Q1 2021 | $1,861,000 | -1.7% | 23,254 | +0.3% | 0.01% | 0.0% |
| Q4 2020 | $1,893,000 | +264.0% | 23,193 | +9.8% | 0.01% | +250.0% |
| Q3 2020 | $520,000 | +146.4% | 21,131 | +180.5% | 0.00% | +100.0% |
| Q2 2020 | $211,000 | +61.1% | 7,532 | +3.6% | 0.00% | 0.0% |
| Q1 2020 | $131,000 | – | 7,271 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $205,573,000 | 24.93% |
| HSG Holding Ltd | 796,089 | $69,268,000 | 6.22% |
| DC Investments Management, LLC | 21,010 | $1,828,000 | 3.41% |
| Redmile Group, LLC | 1,975,006 | $171,845,000 | 3.00% |
| Casdin Capital, LLC | 818,820 | $71,246,000 | 1.77% |
| Evolutionary Tree Capital Management, LLC | 44,390 | $3,862,000 | 1.71% |
| HHLR ADVISORS, LTD. | 1,448,161 | $126,004,000 | 1.65% |
| Nan Fung Group Holdings Ltd | 54,903 | $4,777,000 | 1.53% |
| ARK Investment Management | 6,841,722 | $595,298,000 | 1.43% |
| BRANDYWINE MANAGERS, LLC | 12,900 | $1,122,000 | 1.17% |